Search

Dr Jindriska Lindsay

Haematology 05206092

  • Bupa Platinum consultant
  • is fee assuredFee assured
  • Open Referral network
Overview
Bupa Platinum consultant
Fee assured
Open Referral network

Specialises in

  • Haemato-oncology

About me

I was appointed as a consultant Haemato-oncologist at East Kent Hospitals University Foundation Trust in September 2010 having completed my specialist training on the King's College Hospital London rotation.

My special interest is in myeloma, Waldenstroms macroglobulinemia and other Lymphomas.

I actively participate in cancer research, particularly in myeloma - I am principle investigator for a number of myeloma studies run at East Kent.

Areas of interest

Myeloma; Lymphoma

Medical secretaries

Anaesthetists worked with

  • Dr Jindriska Lindsay has worked with Dr Dragan Nenadic at the following hospitals:

    • Chaucer Hospital (The) (1-5)
About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0004

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)

    Chaucer Hospital (The) (5-50)

  • X0003

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (1-5)

    Chaucer Hospital (The) (1-5)

  • W3650

    Diagnostic aspiration and trephine biopsy of bone marrow, including analysis - (1-5)

    Chaucer Hospital (The) (1-5)

Report this page Edit details

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.